Steven Z Pavletic
Overview
Explore the profile of Steven Z Pavletic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
6159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Volkmann E, Varga J, Blazar B, Pavletic S
Lancet Rheumatol
. 2024 Sep;
6(11):e740-e743.
PMID: 39332423
No abstract available.
12.
Rashidi A, Pidala J, Hamilton B, Pavletic S, Kim K, Zevin A, et al.
Clin Cancer Res
. 2024 Jul;
30(18):4240-4250.
PMID: 39017661
Purpose: Whether and how the oral microbiome and its changes in allogeneic hematopoietic cell transplantation (alloHCT) recipients may contribute to oral chronic GVHD (cGVHD) pathogenesis is unknown. In addition, although...
13.
Pidala J, Carpenter P, Onstad L, Pavletic S, Hamilton B, Chen G, et al.
PLoS One
. 2024 May;
19(5):e0298026.
PMID: 38753616
Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that causes significant late morbidity and mortality following allogeneic hematopoietic cell transplantation. The "Close Assessment and Testing for Chronic GVHD (CATCH)" study...
14.
Holtzman N, Curtis L, Salit R, Shaffer B, Pirsl F, Ostojic A, et al.
Blood Adv
. 2024 Apr;
8(16):4294-4310.
PMID: 38669315
Chronic graft-versus-host disease (cGVHD) remains a significant problem for patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Although in vivo lymphodepletion for cGVHD prophylaxis has been explored in the myeloablative...
15.
Rosenstein R, Rose J, Brooks S, Tsai W, Gadina M, Pavletic S, et al.
JID Innov
. 2024 Feb;
4(2):100246.
PMID: 38357212
Cutaneous sclerotic chronic graft-versus-host disease (cGVHD) is a common and highly morbid complication of allogeneic hematopoietic stem cell transplantation. Our goals were to identify signals active in the skin of...
16.
Mitchell S, Hunter R, Fry A, Pavletic S, Widemann B, Wiener L
Front Psychol
. 2024 Jan;
14:1243005.
PMID: 38259542
Background: Chronic graft-versus-host disease (cGVHD) is a debilitating late complication of hematopoietic stem cell transplantation. It is often accompanied by extensive symptom burden. No validated cGVHD patient-reported outcome (PRO) measure...
17.
Bracken S, Suthers A, DiCioccio R, Su H, Anand S, Poe J, et al.
Blood Adv
. 2023 Dec;
8(3):667-680.
PMID: 38113462
Chronic graft-versus-host disease (cGVHD) is a debilitating, autoimmune-like syndrome that can occur after allogeneic hematopoietic stem cell transplantation. Constitutively activated B cells contribute to ongoing alloreactivity and autoreactivity in patients...
18.
Pang Y, Andargie T, Jang M, Kong H, Park W, Hill T, et al.
iScience
. 2023 Nov;
26(11):108160.
PMID: 38026221
Chronic graft-versus-host disease (cGvHD) is a devastating complication of hematopoietic stem cell transplantation (HSCT). Effective early detection may improve the outcome of cGvHD. The potential utility of circulating cell-free DNA...
19.
20.
Zhao A, Pirsl F, Steinberg S, Holtzman N, Schulz E, Mina A, et al.
Bone Marrow Transplant
. 2023 Sep;
58(12):1377-1383.
PMID: 37684526
Patients with chronic graft-versus-host disease (cGVHD) are at heightened risk for components of metabolic syndrome (MetS), yet the prevalence and impact of MetS in the cGVHD patient population remain unknown....